EQUASHIELD® Named Most-Used CSTD in the U.S. for Eighth Consecutive Year

New PP&P State of Pharmacy Compounding report shows EQUASHIELD® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare environment where safety, consistency, and staff protection are non‑negotiable,...